January 11, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of CAR gene therapy in Japan

2017 2017/01/11 Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of CAR gene therapy in Japan Kusatsu/Shiga, Japan — January 11, 2017 —Takara Bio Inc. (Takara Bio), today announced that it has submitted the Clinical Trial Notification for regenerative medicines to PMDA (Pharmaceuticals and Medical Devices Agency), Japanese regulatory... Read more

January 9, 2017 Clinical Research/Diagn. M&A, Partnerships

COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator

WASHINGTON, D.C. MINNEAPOLIS, MN – January 9, 2017 – The COPD Foundation-sponsored COPD Biomarker Qualification Consortium (CBQC) today announced that it has partnered with the Bio-Techne Corporation, a manufacturer of biotechnology products for life science research and diagnostics. The partnership was established to evaluate the suitability of a soluble form of receptor for advanced glycation... Read more

January 4, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools Product Launch

Edico Genome Offers Bundled Ultra-Rapid Solution for Clinical Genomics and Research

STORY HIGHLIGHTS New Edico Genome bundle offers a pre-configured, out-of-the-box solution for rapid analysis and efficient storage of next-generation sequencing data. Available now, the solution allows for simple implementation for users while reducing storage costs, speeding analysis and maintaining high accuracy. Bundle enables analysis of a whole genome in as little as 22 minutes, which... Read more

December 20, 2016 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal M&A, Partnerships Uncategorized

Agilent Technologies to Acquire Multiplicom N.V., a Leading European Diagnostics Company with State-of-the-Art Genetic Testing Technology and Products

Agilent fortifies its target-enrichment portfolio through its planned acquisition of Multiplicom N.V. SANTA CLARA, Calif. & NIEL, Belgium–(BUSINESS WIRE)–Dec. 20, 2016– Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products.... Read more

December 15, 2016 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus

Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus Kusatsu/Shiga, Japan — December 15, 2016 — Takara Bio Inc. (Takara) announced today that it has entered into an exclusive license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for co-development and commercialization in Japan of the oncolytic virus... Read more

November 28, 2016 Clinical Research/Diagn. M&A, Partnerships

Boston Children’s Hospital and GE Healthcare Working Together to Create Smart Imaging Technology to Better Detect Pediatric Brain Disorders

Chicago, Illinois – November 28, 2016 – Boston Children’s Hospital and GE Healthcare today announced a collaboration to develop and commercialize digital solutions to advance the diagnosis and treatment of specific childhood diseases – starting with diseases that affect the brain. The first project, detailed today at the 102nd annual meeting of the Radiological Society... Read more

September 28, 2016 Clinical Research/Diagn. Product Launch

Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases

Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases MADISON, WIS, September 28, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company and the leading developer and manufacturer of induced pluripotent stem cell (iPSC) products, today announced a new venture, named Opsis Therapeutics. Formed on July 31, Opsis Therapeutics... Read more

September 19, 2016 Cell Analysis Tools Clinical Research/Diagn. Product Launch

CE marked MACS® IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485

BERGISCH GLADBACH, 19. September 2016 – Miltenyi Biotec has expanded its assortment of antibodies with a series of CE marked in vitro-diagnostic medical devices – MACS® IVD Antibodies. They can be used in both clinical flow cytometry and in the quality control of cellular products for translational research. The renowned biotech company from Bergisch Gladbach... Read more

September 1, 2016 Cell Analysis Tools Clinical Research/Diagn.

Cellular Dynamics to Realign Business Units to Better Serve Therapeutic and Life Science Customers

MADISON, WIS, September 1, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced that effective September 1, 2016 the company operations will be divided into two equally important business units. Emile Nuwaysir, PhD, President and Chief Operating Officer of CDI, will lead the Therapeutics Business Unit. The Life Science business unit will be led by... Read more